Literature DB >> 20194506

Targeting the active site gate to yield hyperactive variants of 5-aminolevulinate synthase.

Thomas Lendrihas1, Gregory A Hunter, Gloria C Ferreira.   

Abstract

The rate of porphyrin biosynthesis in mammals is controlled by the activity of the pyridoxal 5'-phosphate-dependent enzyme 5-aminolevulinate synthase (EC 2.3.1.37). Based on the postulate that turnover in this enzyme is controlled by conformational dynamics associated with a highly conserved active site loop, we constructed a variant library by targeting imperfectly conserved noncatalytic loop residues and examined the effects on product and porphyrin production. Functional loop variants of the enzyme were isolated via genetic complementation in Escherichia coli strain HU227. Colony porphyrin fluorescence varied widely when bacterial cells harboring the loop variants were grown on inductive media; this facilitated identification of clones encoding unusually active enzyme variants. Nine loop variants leading to high in vivo porphyrin production were purified and characterized kinetically. Steady state catalytic efficiencies for the two substrates were increased by up to 100-fold. Presteady state single turnover reaction data indicated that the second step of quinonoid intermediate decay, previously assigned as reaction rate-limiting, was specifically accelerated such that in three of the variants this step was no longer kinetically significant. Overall, our data support the postulate that the active site loop controls the rate of product and porphyrin production in vivo and suggest the possibility of an as yet undiscovered means of allosteric regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194506      PMCID: PMC2859533          DOI: 10.1074/jbc.M109.074237

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  The time scale of the catalytic loop motion in triosephosphate isomerase.

Authors:  S Rozovsky; A E McDermott
Journal:  J Mol Biol       Date:  2001-06-29       Impact factor: 5.469

2.  A heme-deficient strain of Escherichia coli has a three-base pair deletion in a "hotspot" in hemA.

Authors:  Juncheng Li; Berthony Deslouches; Sharon D Cosloy; Charlotte Sananes Russell
Journal:  Biochim Biophys Acta       Date:  2003-04-15

3.  C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.

Authors:  Sharon D Whatley; Sarah Ducamp; Laurent Gouya; Bernard Grandchamp; Carole Beaumont; Michael N Badminton; George H Elder; S Alexander Holme; Alexander V Anstey; Michelle Parker; Anne V Corrigall; Peter N Meissner; Richard J Hift; Joanne T Marsden; Yun Ma; Giorgina Mieli-Vergani; Jean-Charles Deybach; Hervé Puy
Journal:  Am J Hum Genet       Date:  2008-09-04       Impact factor: 11.025

4.  A continuous spectrophotometric assay for 5-aminolevulinate synthase that utilizes substrate cycling.

Authors:  G A Hunter; G C Ferreira
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

5.  Analysis of numerical methods for computer simulation of kinetic processes: development of KINSIM--a flexible, portable system.

Authors:  B A Barshop; R F Wrenn; C Frieden
Journal:  Anal Biochem       Date:  1983-04-01       Impact factor: 3.365

6.  Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture.

Authors:  Piotr Ziolkowski; Beata J Osiecka; Gerhard Oremek; Maciej Siewinski; Krzysztof Symonowicz; Yousif Saleh; Andrzej Bronowicz
Journal:  J Exp Ther Oncol       Date:  2004-07

7.  Supraphysiological concentrations of 5-aminolevulinic acid dimerize in solution to produce superoxide radical anions via a protonated dihydropyrazine intermediate.

Authors:  Gregory A Hunter; Edwin Rivera; Gloria C Ferreira
Journal:  Arch Biochem Biophys       Date:  2005-03-22       Impact factor: 4.013

Review 8.  Biosynthesis, biotechnological production and applications of 5-aminolevulinic acid.

Authors:  K Sasaki; M Watanabe; T Tanaka; T Tanaka
Journal:  Appl Microbiol Biotechnol       Date:  2002-01       Impact factor: 4.813

Review 9.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 10.  Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy.

Authors:  Haydée Fukuda; Adriana Casas; Alcira Batlle
Journal:  Int J Biochem Cell Biol       Date:  2005-02       Impact factor: 5.085

View more
  17 in total

1.  Functional asymmetry for the active sites of linked 5-aminolevulinate synthase and 8-amino-7-oxononanoate synthase.

Authors:  Tracy D Turbeville; Junshun Zhang; W Christopher Adams; Gregory A Hunter; Gloria C Ferreira
Journal:  Arch Biochem Biophys       Date:  2011-05-11       Impact factor: 4.013

Review 2.  5-Aminolevulinate synthase catalysis: The catcher in heme biosynthesis.

Authors:  Bosko M Stojanovski; Gregory A Hunter; Insung Na; Vladimir N Uversky; Rays H Y Jiang; Gloria C Ferreira
Journal:  Mol Genet Metab       Date:  2019-06-13       Impact factor: 4.797

3.  Asn-150 of Murine Erythroid 5-Aminolevulinate Synthase Modulates the Catalytic Balance between the Rates of the Reversible Reaction.

Authors:  Bosko M Stojanovski; Gloria C Ferreira
Journal:  J Biol Chem       Date:  2015-10-28       Impact factor: 5.157

4.  Unstable reaction intermediates and hysteresis during the catalytic cycle of 5-aminolevulinate synthase: implications from using pseudo and alternate substrates and a promiscuous enzyme variant.

Authors:  Bosko M Stojanovski; Gregory A Hunter; Martina Jahn; Dieter Jahn; Gloria C Ferreira
Journal:  J Biol Chem       Date:  2014-06-11       Impact factor: 5.157

Review 5.  Molecular enzymology of 5-aminolevulinate synthase, the gatekeeper of heme biosynthesis.

Authors:  Gregory A Hunter; Gloria C Ferreira
Journal:  Biochim Biophys Acta       Date:  2011-01-06

6.  5-Aminolevulinic acid production from inexpensive glucose by engineering the C4 pathway in Escherichia coli.

Authors:  Wenwen Ding; Huanjiao Weng; Guocheng Du; Jian Chen; Zhen Kang
Journal:  J Ind Microbiol Biotechnol       Date:  2017-04-05       Impact factor: 3.346

7.  X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).

Authors:  David F Bishop; Vassili Tchaikovskii; A Victor Hoffbrand; Marie E Fraser; Steven Margolis
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

8.  Molecular expression and characterization of erythroid-specific 5-aminolevulinate synthase gain-of-function mutations causing X-linked protoporphyria.

Authors:  David F Bishop; Vassili Tchaikovskii; Irina Nazarenko; Robert J Desnick
Journal:  Mol Med       Date:  2013-03-05       Impact factor: 6.354

9.  Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release.

Authors:  Erica J Fratz; Jerome Clayton; Gregory A Hunter; Sarah Ducamp; Leonid Breydo; Vladimir N Uversky; Jean-Charles Deybach; Laurent Gouya; Hervé Puy; Gloria C Ferreira
Journal:  Biochemistry       Date:  2015-09-02       Impact factor: 3.162

10.  Catalytically active alkaline molten globular enzyme: Effect of pH and temperature on the structural integrity of 5-aminolevulinate synthase.

Authors:  Bosko M Stojanovski; Leonid Breydo; Gregory A Hunter; Vladimir N Uversky; Gloria C Ferreira
Journal:  Biochim Biophys Acta       Date:  2014-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.